Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253

References

• Ferro A, Rosato V, Rota M, et al. Meat intake and risk of gastric cancer in the Stomach cancer Pooling (StoP) project. Int J Cancer. 2020;147(1):45–55. DOI:10.1002/ijc.32707
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. DOI:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Orditura M, Galizia G, Sforza V, et al. Treatment of gastric cancer. World J Gastroenterol. 2014;20(7):1635–1649. DOI:10.3748/wjg.v20.i7.1635
   PubMed Web of Science ®Google Scholar
• Lordick F, Lorenzen S, Yamada Y et al. Optimal chemotherapy for advanced gastric cancer: is there a global consensus? Gastric Cancer. 2014;17(2):213–225. DOI:10.1007/s10120-013-0297-z
   PubMed Web of Science ®Google Scholar
• Liu C, Liu Q, Yan A, et al. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells. Cancer Med. 2020;9(11):3875–3884. DOI:10.1002/cam4.3029
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–1022 doi:10.1038/ni.2703.
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437 doi:10.1038/nm.3394.
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61 doi:10.1016/j.immuni.2014.06.010.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A et al. Cancer-related inflammation. Nature. 2008;454(7203):436–444. DOI:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Yuan M, Zou X, Liu S, et al. Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ. Biomed Pharmacother. 2020;129:110440 doi:10.1016/j.biopha.2020.110440.
   PubMed Web of Science ®Google Scholar
• Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27(4):462–472 doi:10.1016/j.ccell.2015.02.015.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232 doi:10.1016/j.cell.2016.01.043.
   PubMed Web of Science ®Google Scholar
• Boelens MC, Wu T, Nabet B, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014;159(3):499–513. DOI:10.1016/j.cell.2014.09.051
   PubMed Web of Science ®Google Scholar
• Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145. DOI:10.1038/s41392-020-00261-0
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang D, Ding Y, et al. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p. Biotechnol Lett. 2021;43(2):339–351. DOI:10.1007/s10529-020-03036-3
   PubMed Web of Science ®Google Scholar
• Njau F, Haller H. Calcium dobesilate modulates PKCδ-NADPH oxidase- MAPK-NF-κB signaling pathway to reduce CD14, TLR4, and MMP9 expression during monocyte-to-macrophage differentiation: potential therapeutic implications for atherosclerosis. Antioxidants (Basel). 2021;10(11):1798 doi:10.3390/antiox10111798.
   PubMedGoogle Scholar
• Yamaguchi T, Fushida S, Yamamoto Y, et al. Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. Oncol Rep. 2017;37(6):3341–3350. DOI:10.3892/or.2017.5586
   PubMed Web of Science ®Google Scholar
• Zheng P, Chen L, Yuan X, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017;36(1):53. DOI:10.1186/s13046-017-0528-y
   PubMed Web of Science ®Google Scholar
• Sun D, Cao H, Yang L, et al. MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3. Cell Death Dis. 2020;11(6):480. DOI:10.1038/s41419-020-2685-8
   PubMed Web of Science ®Google Scholar
• Huang Z, Xie C, Huang Z, et al. Anti-tumor effect of pcDNA3.1(-)/rmetase-shUCA1 hyaluronic acid-modified G5 polyamidoamine nanoparticles on gastric cancer. Aging Pathobiology Ther. 2020;2(2):86–95. DOI:10.31491/APT.2020.06.019
   Google Scholar
• Zhang P, Shi L, Zhang T, et al. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. Cell Oncol (Dordr). 2019;42(6):847–860. DOI:10.1007/s13402-019-00471-x
   PubMed Web of Science ®Google Scholar
• Tang R, Zhang Z, Han W. CircLRRK1 targets miR-223-3p to inhibit the proliferation, migration and invasion of trophoblast cells by regulating the PI3K/AKT signaling pathway. Placenta. 2021;104:110–118 doi:10.1016/j.placenta.2020.12.003.
   PubMed Web of Science ®Google Scholar
• Chen H, Gu B, Zhao X, et al. Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase II alpha (MAT2A) expression by restraining microRNA-101-5p. Bioengineered. 2020;11(1):1269–1279. DOI:10.1080/21655979.2020.1832343
   PubMed Web of Science ®Google Scholar
• Szakács G, Annereau J-P, Lababidi S, et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell. 2004;6(2):129–137. DOI:10.1016/j.ccr.2004.06.026
   PubMed Web of Science ®Google Scholar
• Yashiro M, Nishii T, Hasegawa T, et al. A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. Br J Cancer. 2013;109(10):2619–2628. DOI:10.1038/bjc.2013.638
   PubMed Web of Science ®Google Scholar
• Xia T, Pan Z, Zhang J. CircSMC3 regulates gastric cancer tumorigenesis by targeting miR-4720-3p/tjp1 axis. Cancer Med. 2020;9(12):4299–4309 doi:10.1002/cam4.3057.
   PubMed Web of Science ®Google Scholar
• An O, Song Y, Ke X, et al. “3G” trial: an RNA editing signature to guide gastric cancer chemotherapy. Cancer Res. 2021;81(10):2788–2798. DOI:10.1158/0008-5472.CAN-20-2872
   PubMed Web of Science ®Google Scholar
• Sun Y, Xie Y, Tang H, et al. In vitro and in vivo evaluation of a novel estrogen-targeted PEGylated oxaliplatin liposome for gastric cancer. Int J Nanomedicine. 2021;16:8279–8303 doi:10.2147/ijn.S340180.
   PubMed Web of Science ®Google Scholar
• Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2015;25(4):198–213 doi:10.1016/j.tcb.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Weizman N, Krelin Y, Shabtay-Orbach A, et al. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase. Oncogene. 2014;33(29):3812–3819. DOI:10.1038/onc.2013.357
   PubMed Web of Science ®Google Scholar
• Ruivo CF, Adem B, Silva M, et al. The biology of cancer exosomes: insights and new perspectives. Cancer Res. 2017;77(23):6480–6488. DOI:10.1158/0008-5472.CAN-17-0994
   PubMed Web of Science ®Google Scholar
• Malla RR, Shailender G, Kamal MA. Exosomes: critical mediators of tumour microenvironment reprogramming. Curr Med Chem. 2021;28(39):8182–8202 doi:10.2174/0929867328666201217105529.
   PubMed Web of Science ®Google Scholar
• Alharbi M, Lai A, Guanzon D, et al. Ovarian cancer-derived exosomes promote tumour metastasis in vivo: an effect modulated by the invasiveness capacity of their originating cells. Clin Sci (Lond). 2019;133(13):1401–1419. DOI:10.1042/CS20190082
   PubMed Web of Science ®Google Scholar
• Cui HY, Rong J-S, Chen J, et al. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells. World J Gastroenterol. 2021;27(36):6079–6092. DOI:10.3748/wjg.v27.i36.6079
   PubMed Web of Science ®Google Scholar
• Sun J-F, Wu, S.L., Wang, G.J, et al. Roles of circular RNAs and their interactions with microRNAs in human disorders. Clin Surg Res Commun. 2018;2(2):1–8. DOI:10.31491/CSRC.2018.6.012
   Google Scholar
• Yu YZ, Lv D-J, Wang C, et al. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Mol Cancer. 2022;21(1):12. DOI:10.1186/s12943-021-01480-x
   PubMed Web of Science ®Google Scholar
• Zhu X, Han J, Lan H, et al. A novel circular RNA hsa_circrna_103809/mir-377-3p/got1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC). BMC Cancer. 2020;20(1):1190. DOI:10.1186/s12885-020-07680-w
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu H, Li W, et al. CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630. Aging (Albany NY). 2017;9(6):1585–1594. DOI:10.18632/aging.101254
   PubMedGoogle Scholar